BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35483609)

  • 21. Prevalence of Hepatitis C Virus Infection in the Veteran Population Undergoing Total Joint Arthroplasty: An Update.
    Shapiro CBH; Cheung RC; Giori NJ
    J Arthroplasty; 2021 Feb; 36(2):467-470. PubMed ID: 32900563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of topical vancomycin powder for the prevention of surgical site infections in primary total hip and knee arthroplasty: A meta-analysis.
    Peng Z; Lin X; Kuang X; Teng Z; Lu S
    Orthop Traumatol Surg Res; 2021 Jun; 107(4):102741. PubMed ID: 33257290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undetectable Hepatitis C Viral Load Is Associated With Improved Outcomes Following Total Joint Arthroplasty.
    Novikov D; Feng JE; Anoushiravani AA; Vigdorchik JM; Lajam CM; Seyler TM; Schwarzkopf R
    J Arthroplasty; 2019 Dec; 34(12):2890-2897. PubMed ID: 31351854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between body mass index and two-stage revision failure of periprosthetic joint infection following total joint arthroplasty: A systematic review and meta-analysis.
    Guo J; Wu S; Wang H; Chen W; Deng X
    J Orthop Surg (Hong Kong); 2021; 29(3):23094990211055231. PubMed ID: 34913757
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose-Dependent Early Postoperative Opioid Use Is Associated with Periprosthetic Joint Infection and Other Complications in Primary TJA.
    Chung BC; Bouz GJ; Mayfield CK; Nakata H; Christ AB; Oakes DA; Lieberman JR; Heckmann ND
    J Bone Joint Surg Am; 2021 Aug; 103(16):1531-1542. PubMed ID: 34043598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating Hepatitis C Prior to Total Hip Arthroplasty is Cost-effective: A Markov Analysis.
    Anoushiravani AA; Kalyanasundaram G; Feng JE; Congiusta F; Iorio R; DiCaprio MR
    J Arthroplasty; 2023 Jul; 38(7 Suppl 2):S84-S90. PubMed ID: 36878438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Prior Bariatric Surgery Improve Outcomes Following Total Joint Arthroplasty in the Morbidly Obese? A Meta-Analysis.
    Li S; Luo X; Sun H; Wang K; Zhang K; Sun X
    J Arthroplasty; 2019 Mar; 34(3):577-585. PubMed ID: 30528132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased rates of periprosthetic joint infection in patients with cirrhosis undergoing total joint arthroplasty.
    Jiang SL; Schairer WW; Bozic KJ
    Clin Orthop Relat Res; 2014 Aug; 472(8):2483-91. PubMed ID: 24711129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Immunodeficiency Virus and Total Joint Arthroplasty: The Risk for Infection Is Reduced.
    Enayatollahi MA; Murphy D; Maltenfort MG; Parvizi J
    J Arthroplasty; 2016 Oct; 31(10):2146-51. PubMed ID: 27131415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C Is Associated With Higher Short-Term Complication Rates After Initial Aseptic and Septic Revision Total Hip Arthroplasty: A Matched Cohort Study.
    Ross BJ; Cole MW; Ross AJ; Guild GN; Lee OC; Sherman WF
    J Arthroplasty; 2023 Mar; 38(3):548-554. PubMed ID: 36130698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective single-stage revision using intra-articular antibiotic infusion after multiple failed surgery for periprosthetic joint infection : a mean seven years' follow-up.
    Ji B; Li G; Zhang X; Xu B; Wang Y; Chen Y; Cao L
    Bone Joint J; 2022 Jul; 104-B(7):867-874. PubMed ID: 35775176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longer Operative Time Results in a Higher Rate of Subsequent Periprosthetic Joint Infection in Patients Undergoing Primary Joint Arthroplasty.
    Wang Q; Goswami K; Shohat N; Aalirezaie A; Manrique J; Parvizi J
    J Arthroplasty; 2019 May; 34(5):947-953. PubMed ID: 30765229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inadequate Glycemic Control Is Associated With Increased Surgical Site Infection in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis.
    Shohat N; Muhsen K; Gilat R; Rondon AJ; Chen AF; Parvizi J
    J Arthroplasty; 2018 Jul; 33(7):2312-2321.e3. PubMed ID: 29605149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
    Li T; Qu Y; Guo Y; Wang Y; Wang L
    Liver Int; 2017 Jul; 37(7):974-981. PubMed ID: 27943605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.
    Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Law M; Janjua NZ; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore GJ; Grebely J
    J Hepatol; 2020 Apr; 72(4):643-657. PubMed ID: 31785345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with a History of Treated Septic Arthritis are at High Risk of Periprosthetic Joint Infection after Total Joint Arthroplasty.
    Sultan AA; Mahmood B; Samuel LT; George J; Faour M; Pelt CE; Anderson MB; Klika AK; Higuera CA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1605-1612. PubMed ID: 30913112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
    Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for periprosthetic joint infection following primary total hip or knee arthroplasty: a meta-analysis.
    Kong L; Cao J; Zhang Y; Ding W; Shen Y
    Int Wound J; 2017 Jun; 14(3):529-536. PubMed ID: 27397553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression.
    Hosseini-Hooshyar S; Hajarizadeh B; Bajis S; Law M; Janjua NZ; Fierer DS; Chromy D; Rockstroh JK; Martin TCS; Ingiliz P; Hung CC; Dore GJ; Martinello M; Matthews GV
    Lancet HIV; 2022 Jun; 9(6):e414-e427. PubMed ID: 35659336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red Cell Distribution Width: An Unacknowledged Predictor of Mortality and Adverse Outcomes Following Revision Arthroplasty.
    Aali-Rezaie A; Alijanipour P; Shohat N; Vahedi H; Foltz C; Parvizi J
    J Arthroplasty; 2018 Nov; 33(11):3514-3519. PubMed ID: 30072185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.